glp 1 drug market GLP-1 Size, Scope, Forecast Report 2026 to 2035 GLP-1 Antagonists Increase Plan Drug
Description
Key Points Three companies to watch in the fast-growing GLP-1 space include firms with market capitalizations ranging from about $4 billion to nearly $1 trillion
doi: 10.2337/dc15-2479 76 AhrnBLeguizamo DimasAMiossecPSaubaduSAronsonR
Researchers found that overweight adults without diabetes lost an average of 16% of body weight over the course of 68 weeks when they received a once-weekly subcutaneous 2.4 mg semaglutide injection
The disproportionality signal they identified disappeared only when they removed this subgroup of patients from their analysis
